Sustained release GLP-1 receptor modulators
First Claim
Patent Images
1. A pharmaceutical composition comprising a GLP-1 receptor modulator selected from SEQ ID NOs:
- 9, 15, 118, 151 and 158; and
a metal ion, a protamine adduct, or a combination thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides novel pharmaceutical compositions comprising a human glucagon-like peptide-1 (GLP-1)-receptor modulator as an active ingredient in a sustained release formulation.
56 Citations
25 Claims
-
1. A pharmaceutical composition comprising a GLP-1 receptor modulator selected from SEQ ID NOs:
- 9, 15, 118, 151 and 158; and
a metal ion, a protamine adduct, or a combination thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
- 9, 15, 118, 151 and 158; and
Specification